Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The most common type of cutaneous T-cell lymphoma is mycosis fungoides and its leukemic variant, Sezary syndrome. The other more commonly seen forms of cutaneous lymphoma include the CD30 positive lymphoproliferative disorders (CD30+ LPDs). Whereas primary cutaneous anaplastic large cell lymphoma (pcALCL) is a malignant CD30+ LPD, the benign spectrum of the CD30+ LPDs includes lymphomatoid papulosis.
We are expert in the diagnosis, treatment, and investigation of these and other forms of cutaneous T-cell lymphoma. We are also expert in the diagnosis, treatment, and investigation of cutaneous B-cell lymphomas, including primary cutaneous marginal zone lymphoma, primary cutaneous follicle center cell lymphoma, and primary cutaneous diffuse large B-cell lymphoma (including leg-type).
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.